Morning Headlines 9/23/26
A health IT headline roundup noting our name change to Concurrence and the Databricks partnership.
Newsroom
Selected coverage and announcements from Concurrence, formerly Amigo AI.
Coverage reflects its publication date. Historical headlines retain the company name used by the publisher.
For current funding information, see our Series A announcement.
Read the story behind our new nameConcurrence has completed its 2026 HITRUST e1 assessment. Final reports are available for security review through our Trust Center. The assessment is recorded as Amigo AI 2026 e1 under Amigo, Inc., the legal entity behind Concurrence.
Concurrence, formerly Amigo (Amigo AI), connects healthcare data, configured AI agent workflows, and human operations. Healthcare organizations use the platform to configure clinical agents, train them through Digital Residency, integrate with clinical systems, and monitor their performance.
Yes. Amigo announced its rebrand to Concurrence on September 21, 2026. Amigo and Amigo AI are former brand names; the legal entity remains Amigo, Inc.
Concurrence’s New York office is at 373 Park Ave S, Floor 2, New York, NY 10016. Office phone: +1 (929) 996-1890. Our office is on the second floor. The building has a doorman. Coordinate arrival details with your Concurrence contact before your visit.
Ali Khokhar and John Xing co-founded Concurrence. Ali is Co-Founder & CEO; John is Co-Founder & CTO.
Dr. Jay Shah, MD is Concurrence’s Chief Medical Officer. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine, where he served as Chief of Medical Staff.
Dr. Hythem Sidky is Concurrence’s Head of Applied AI. He leads enterprise healthcare AI deployments and previously led the NIH National Clinical Cohort Collaborative (N3C) while at Axle Research and Technologies.
01
Reporting and industry roundups published under our current and former names.
A health IT headline roundup noting our name change to Concurrence and the Databricks partnership.
A health technology funding roundup covering our Series A alongside Grow Therapy.
A weekly industry roundup that includes our Series A in its funding coverage.
Coverage of Jay Shah’s appointment as chief medical advisor at Amigo AI.
A report on our Series A and the Digital Residency process used to train patient-facing clinical agents.
Coverage of our Series A funding. Subscription required.
Reporting on the announced Amigo–Eucalyptus partnership and planned use of AI health assistants in virtual care.
A seed-funding mention in the Pro Rata newsletter.
02
Company-issued releases distributed by newswire services, separate from media coverage.
Our company announcement appointing Dr. Hythem Sidky as Head of Applied AI to lead enterprise healthcare AI deployments. He previously led the NIH National Clinical Cohort Collaborative while at Axle Research and Technologies.
Our company-issued announcement of a multi-year Databricks partnership focused on Health World Models, healthcare AI agents, and learning from patient outcomes.
Our company announcement introducing the Concurrence name and the next stage of our healthcare AI platform.
Our company-issued Series A announcement, distributed by Business Wire.
Our company announcement naming Dr. Jay Shah, then chief of medical staff at Stanford Health Care, as chief medical advisor and first member of our Medical Advisory Board.
03
Company interviews, partner and investor commentary, and paid features, with the relationship identified for each publication.
A partner-authored look at patient context, simulation, and AI governance at an annualized rate of roughly 1.2 trillion production input tokens. Unity Gateway governs developer AI; real-time clinical inference remains on existing providers pending the required compliance coverage.
Madrona’s investment rationale and perspective on training clinical agents. Madrona is an investor in Concurrence.
A sponsored walkthrough of how Amigo builds and trains clinical agents. This is paid coverage, not independent validation.
A feature presented together with Concurrence on clinician co-creation, simulation, validation, and ongoing oversight of clinical AI agents.
An interview with co-founder and CEO Ali Khokhar about simulation, clinician involvement, and building trust in healthcare AI agents.
04
For interviews, comment, or background, email our team and include your outlet and deadline.